130 related articles for article (PubMed ID: 32931629)
1. Scrofula associated with a patient receiving adalimumab therapy for Crohn disease.
Hunt WTN; Wheeler JF; Kennedy NA; Burden T; McGrath EJ
Clin Exp Dermatol; 2021 Jan; 46(1):216-218. PubMed ID: 32931629
[No Abstract] [Full Text] [Related]
2. [Development of cervical tuberculous lymphadenitis in a patient with Crohn's disease receiving infliximab despite of chemoprophylaxis with isoniazid].
Ikeue T; Nakagawa A; Furuta K; Morita K; Sugita T; Nishiyama H
Kekkaku; 2011 Nov; 86(11):879-82. PubMed ID: 22250467
[TBL] [Abstract][Full Text] [Related]
3. Extra-pulmonary Reactivation of Latent Tuberculosis After Initiation of Anti-tumour Necrosis Factor Therapy for Inflammatory Bowel Disease-Are Current Screening Strategies Adequate?
Tranah TH; Luk SY; Gess M
J Crohns Colitis; 2017 Jun; 11(6):762-763. PubMed ID: 27932451
[No Abstract] [Full Text] [Related]
4. Bacteriologically Determined De Novo Tuberculosis during Tumor Necrosis Factor-α Inhibitor Therapy.
Takahashi G; Kobayashi H; Saito Y; Ohsawa S; Suzuki K; Ishihara S; Hisada T
Intern Med; 2019 Dec; 58(24):3593-3596. PubMed ID: 31434822
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy.
Ferrer Bradley I; Maroto Arce N; Mora Escrig M; Hinojosa Del Val J
Gastroenterol Hepatol; 2019; 42(6):387-388. PubMed ID: 30042000
[No Abstract] [Full Text] [Related]
6. Mediterranean spotted fever in a patient with Crohn's disease under adalimumab: First case report and review of the literature.
Santos-Antunes J; Nunes AC; Macedo G
Gastroenterol Hepatol; 2015; 38(6):379-80. PubMed ID: 25073681
[No Abstract] [Full Text] [Related]
7. TB or Not TB: Crohn's Disease, Peritoneal Tuberculosis, or Both?
Miller M; Vu KN; Zemek A; Shelton A; Kin C
Dig Dis Sci; 2019 Jun; 64(6):1432-1435. PubMed ID: 30334111
[No Abstract] [Full Text] [Related]
8. Adalimumab-Receiving Ulcerative Colitis Patient Suffered Latent Tuberculosis Reactivation Despite Correct Chemoprophylaxis and was Successfully Treated while on Anti-Tumour Necrosis Factor Therapy.
Agudo B; Díaz G; González-Lama Y
J Crohns Colitis; 2016 Dec; 10(12):1453-1454. PubMed ID: 27215554
[No Abstract] [Full Text] [Related]
9. Palmoplantar pustulosis by adalimumab in a patient with Crohn disease.
Ortiz Salvador JM; Cubells Sánchez L; Subiabre Ferrer D
Med Clin (Barc); 2016 Dec; 147(12):565. PubMed ID: 27431884
[No Abstract] [Full Text] [Related]
10. Impact of Anti-TNFα Antibodies on the Risk of Covid-19 and its Severity in Patients with Inflammatory Bowel Diseases.
Tursi A; Papa A
J Crohns Colitis; 2020 Nov; 14(11):1646-1647. PubMed ID: 32303756
[No Abstract] [Full Text] [Related]
11. [Tuberculous liver abscess, anti-TNF alpha, and immune reconstitution inflammatory syndrome].
Dussouillez G; Zayet S; Kone D; Royer PY; Toko-Tchuindzie L; Ruyer O; Gendrin V
Med Mal Infect; 2020 Feb; 50(1):90-91. PubMed ID: 31477453
[No Abstract] [Full Text] [Related]
12. Miliary tuberculosis during adalimumab therapy in Crohn's disease.
Ameneiros-Lago E; Vázquez Bueno JA; Garrido Sanjuan JA
Med Clin (Barc); 2018 May; 150(10):412. PubMed ID: 28743405
[No Abstract] [Full Text] [Related]
13. Reactivation of latent tuberculosis in a Crohn's patient after TB prophylaxis treated with adalimumab.
Caldera F; Grimes I; Soni A
Am J Gastroenterol; 2013 Jul; 108(7):1181-2. PubMed ID: 23821003
[No Abstract] [Full Text] [Related]
14. Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn's disease treated with adalimumab.
Martín Varas C; Heras M; Saiz A; Coloma R; Calle L; Callejas R; Molina Á; Rodríguez MA; Fernández-Reyes Luis MJ
Nefrologia; 2017; 37(5):560-561. PubMed ID: 28946973
[No Abstract] [Full Text] [Related]
15. Asymptomatic choroidal tubercle in a patient with Crohn's disease on adalimumab treatment.
Asensio-Sánchez VM; Díaz-Cabanas L; Martín-Prieto A; Haro-Álvarez B
Arch Soc Esp Oftalmol (Engl Ed); 2018 Mar; 93(3):147-150. PubMed ID: 28743416
[TBL] [Abstract][Full Text] [Related]
16. IgA nephropathy onset in a Crohn's disease patient treated with Adalimumab.
Bruzzese V; Lorenzetti R; Rosa M; Di Giulio S; Hassan C; Costas G; Zullo A
Minerva Gastroenterol Dietol; 2016 Jun; 62(2):223-4. PubMed ID: 27091038
[No Abstract] [Full Text] [Related]
17. Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.
Ramos GP; Stroh G; Al-Bawardy B; Faubion WA; Papadakis KA; Escalante P
Inflamm Bowel Dis; 2018 Sep; 24(10):2272-2277. PubMed ID: 29718223
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous Resolution of Enterocutaneous Fistula After Disseminated Tuberculosis Treatment in a Patient With Crohn's Disease: Challenges in Biologic Therapy.
Silva JC; Rodrigues A; Carvalho J
Inflamm Bowel Dis; 2020 Jan; 26(1):e1-e2. PubMed ID: 31750911
[No Abstract] [Full Text] [Related]
19. Acute kidney injury caused by COVID-19 in a patient with Crohn's disease treated with adalimumab.
Lenti MV; Gregorini M; Borrelli de Andreis F; Rampino T; D'Ambrosio G; Verga L; Vanoli A; Mengoli C; Ravetta V; Paulli M; Di Sabatino A
J Clin Pathol; 2021 Aug; 74(8):540-542. PubMed ID: 32820044
[No Abstract] [Full Text] [Related]
20. Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents.
Kim ES; Song GA; Cho KB; Park KS; Kim KO; Jang BI; Kim EY; Jeon SW; Lee HS; Yang CH; Lee YK; Lee DW; Kim SK; Kim TO; Lee J; Kim HW; Jee SR; Park SJ; Kim HJ
World J Gastroenterol; 2015 Mar; 21(11):3308-16. PubMed ID: 25805938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
